APOE3 Christchurch modulates β-catenin/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer's cases.

Saved in:
Bibliographic Details
Title: APOE3 Christchurch modulates β-catenin/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer's cases.
Authors: Perez-Corredor P; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, United States., Vanderleest TE; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, United States., Vacano GN; Vacano Informatics LLC, Arvada, CO, United States., Sanchez JS; Massachusetts General Hospital and Department of Neurology at Harvard Medical School, Boston, MA, United States., Villalba-Moreno ND; Molecular Neuropathology of Alzheimer's Disease, Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Marino C; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, United States., Krasemann S; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mendivil-Perez MA; The Neuroscience Group of Antioquia, University of Antioquia, Medellín, Colombia., Aguillón D; The Neuroscience Group of Antioquia, University of Antioquia, Medellín, Colombia., Jiménez-Del-Río M; The Neuroscience Group of Antioquia, University of Antioquia, Medellín, Colombia., Baena A; The Neuroscience Group of Antioquia, University of Antioquia, Medellín, Colombia., Sepulveda-Falla D; Molecular Neuropathology of Alzheimer's Disease, Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Lopera F; The Neuroscience Group of Antioquia, University of Antioquia, Medellín, Colombia., Quiroz YT; Massachusetts General Hospital and Department of Neurology at Harvard Medical School, Boston, MA, United States.; The Neuroscience Group of Antioquia, University of Antioquia, Medellín, Colombia.; Massachusetts General Hospital and Department of Psychiatry at Harvard Medical School, Boston, MA, United States., Arboleda-Velasquez JF; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, United States., Mazzarino RC; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, United States.
Source: Frontiers in molecular neuroscience [Front Mol Neurosci] 2024 Mar 20; Vol. 17, pp. 1373568. Date of Electronic Publication: 2024 Mar 20 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101477914 Publication Model: eCollection Cited Medium: Print ISSN: 1662-5099 (Print) Linking ISSN: 16625099 NLM ISO Abbreviation: Front Mol Neurosci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1662-5099
DOI:10.3389/fnmol.2024.1373568